Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I agree.
That's why I only kept my "free shares"
Glad I took profits.
Realistically, I think $14 is a fair guess with approval.
I still think it will run back up a bit before notification., but the likelihood of approval IMO is 90%
So I kept 25% of my position.
OREX working it's way back after a fairly big pullback.
Should've a nice ride up to PDUFA on Sept 11
Sold them again today at 10.78 again
Bought 25% back at 10.60 ( free shares) now
Thanks for the tip.
I started a position here with 1,000 shares at $8.60
Good luck to us!
The target is supposed to be the price in 12 months according to experts following the stock.
I like the risk:reward on this one down here.
IMO, 90% chance for 40% gain!
I hope those targets are correct. I added more at 4.05
GLTU
I certainly would not to be short this close to July 27.
May see some covering soon which will drive this up very quickly here.
Got very lucky on this one.
Sold all a short time back at 10.78 for a nice gain and now bought them all back at. 9.40
Sometimes everything lines up!
Best of luck to us !
Glad I bought back in this AM
Looking very good here!
Looking good for re-entry here.
Good chance for approval on the 27th.
May grab a starter position this AM?
I agree
Good move
Back on watch here for a bounce
World events. Nothing to do with this particular play IMO.
Looks like an amazing opportunity IMO
I always keep cash available for days like today.
Agree 100%
OREX
Just bought another big block at 5.03
Very interesting price action for a stock with a PDUFA Sept 11
Just bought a lot more at 5.03
I'm not sure why we are seeing the price drop so dramatically.
I'm in this for the eventual news on re-submission to the FDA.
IMO, this has an excellent chance for approval this time around, and I'm holding on to my shares. It's true that owning some of these small bio techs through these big negative moves can really try your patience.
Good luck to us.
OREX
Looking way oversold down here!!
Could double from these levels with PDUFA 9/11 IMO
Yes
Looks way oversold down here.
Great opportunity to accumulate cheap shares IMO
Good luck to us
Holding on tight to my shares and I continue to accumulate more on the way down.
I have high hopes for this one, especially from these levels.
Just sold position at 34.50
Sold all this AM preMarket around 45.93 for a nice gain.
HRTX
Bought more on the dip yesterday.
Excellent entry. I bought at 44.12
I think the buying opportunity will come today in the low $44's
I agree with your add on OREX.
I've been averaging down on the pull back.
We should see a nice run up into PDUFA on 9/11 IMO
OREX
Big pull back here from $6.20
Looking very attractive at $5.45 IMO
Should double from these levels headed into PDUFA date of 9/11 IMO
VSTM
Analysts at Oppenheimer assumed coverage on shares of Verastem (NASDAQ:VSTM) in a research report issued to clients and investors on Monday, TheFlyOnTheWall.com reports. The firm set a “market perform” rating and a $8.99 price target on the stock. Oppenheimer’s price objective indicates a potential upside of 6.52% from the stock’s previous close.
Separately, analysts at Deutsche Bank initiated coverage on shares of Verastem in a research note on Tuesday, May 6th. They set a “buy” rating and a $14.00 price target on the stock. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. Verastem currently has an average rating of “Buy” and an average target price of $19.14.
Sounds pretty good to me from where it closed yesterday?
Analysts at Oppenheimer assumed coverage on shares of Verastem (NASDAQ:VSTM) in a research report issued to clients and investors on Monday, TheFlyOnTheWall.com reports. The firm set a “market perform” rating and a $8.99 price target on the stock. Oppenheimer’s price objective indicates a potential upside of 6.52% from the stock’s previous close.
Separately, analysts at Deutsche Bank initiated coverage on shares of Verastem in a research note on Tuesday, May 6th. They set a “buy” rating and a $14.00 price target on the stock. One investment analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. Verastem currently has an average rating of “Buy” and an average target price of $19.14.
More likely to be the overall market tanking rather than any specific stock or company issue IMO.
The sell off has been deep and broad across many different sectors.
Good move IMO
Good luck to us
Bought another 1,000 at 1.78
Good day to add to positions
No
Just a starter position of 1000 shares.
Thinking of picking up another block down here ?
Big correction here past two days on no news.
Looks oversold and a great entry point IMO.
I'm buying more and averaging down.
Started a position here today at 1.91
Very funny. Great day to add.
I also just picked up some ATHX